Cannabis Legislative Update
March 28, 2017
This week’s Cannabis Legislative Update has a few states introducing bills designed to protect established markets and create new ones. As more states move forward with cannabis legislation, we’ll continue providing relevant updates that affect our industry and your business. Something we missed? Let us know here and we’ll make sure to include it in next week’s post!
Newly introduced legislation will remove some of the residency restrictions for individuals moving to Colorado hoping to enter the cannabis industry. Currently, potential employees must prove residency at the time they apply by providing a utility bill or pay stub. If passed, SB 187 would allow the state licensing authority to create an exemption for occupational licenses for participation in cannabis-based work or education.
Senate Bill 00011, a bill to legalize and tax cannabis sales to adults 21 and over, was heard at a Judiciary Public Hearing on March 22nd. Several cannabis industry professionals, including John Hudak from the Brookings Institution, provided expert testimony, though the day ended in a virtual draw.
Known as the Controlled Substances Therapeutic Relief Act, SB 296 would repeal the Low THC Oil Patient Registry in addition to adding more qualifying conditions. The bill also seeks to provide protections for Georgia business owners and patients from Federal interference.
A bi-partisan committee in Indiana has introduced legislation that would allow cannabidiol access to people suffering from epilepsy. The bill would create a pilot study and research how individuals suffering from intractable epilepsy react to CBD medication. If passed, SB0015 would also require the state to create a patient registry system.
Introduced in the 105th Legislature, The Medical Cannabis Act would establish a patient registry, list of qualifying medical conditions, and guidelines for caregivers. Nebraska is one of the last states without some form of medical cannabis access.
Legislation introduced by cannabis advocate Tick Segerblom seeks to provide an early start for Nevada’s recreational cannabis industry. If passed, SB 302 would have adult use facilities operational by 1/1/2018.
Oklahoma Representative Jon Echols has sponsored a bill that would authorize clinical trials and establish qualifying conditions for medical cannabis. SB 745 would go into effect November 1, 2017 if passed.
A recent update to the SC Compassionate Care Act would exempt dispensaries from paying state sales taxes, opting instead, to pursue a separate tax structure. Act S0212 would also provide patients and physicians with protections from law enforcement.
HJR111 proposes a constitutional amendment to authorize and regulate cannabis for medical use. As demonstrated in Florida, a constitutional amendment is an effective, though controversial, way to gain access to medical cannabis in the face of governing opposition.
A bill to authorize medical cannabis use in West Virginia is making progress. SB 386, known as the Medical Cannabis Act, was approved 6-5 by the Senate’s Health and Human Resources Committee.
Since 2010, BioTrack has provided the legal cannabis operators with the industries’ leading seed to sale tracking and dispensary point of sale software. Whether you operate a cultivation site, manufacturing and processing facility, medical or recreational dispensary or a business that covers the full vertical, we’ve got you covered when it comes to compliance.
Our extensive seed-to-sale software allows licensed operators to remain compliant while helping to identify key data points to streamline and optimize inventory management at each phase of the operation; cultivation, processing, destruction and waste, transportation, lab testing and dispensing.
Along with BioTrack’s best-in-class commercial software, we also provide government track and trace solutions and currently hold government contracts in nine states. This allows lawmakers and regulatory agencies to ensure a transparent and compliant program from top to bottom.
In 2021 BioTrack became a part of Forian, Inc. Forian is a Delaware corporation created by the combination of Helix Technologies, Inc. (“Helix”) and Medical Outcomes Research Analytics, LLC (“MOR”). As of March 2, 2021, each of Helix and MOR are wholly owned subsidiaries of Forian. Forian represents the unique intersection of a leading cannabis technology platform with intelligent data science yielding the combined power to drive innovation and transparency across the healthcare and cannabis industries. For more information,see our website, which remains in process.
Are you interested in learning more about BioTrack or the cannabis industry in general? Check out our careers page to learn more about what it takes to join our winning team or take a look at our industry-leading blog for great news and information about the cannabis industry.
Make sure you’re following BioTrack social media for regular news and updates. Sign up for the CannaPulse newsletter for regular updates right to your inbox!